Lv11
66 积分 2023-11-30 加入
Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma
2小时前
已完结
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
16天前
已完结
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
30天前
已完结
Engineered T cells: the promise and challenges of cancer immunotherapy
1个月前
已完结
Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis
1个月前
已完结
CD70-expressing CD4 T cells produce IFN-γ and IL-17 in rheumatoid arthritis
1个月前
已完结
Natural killer cell therapies
2个月前
已完结
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy
2个月前
已完结
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
2个月前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2个月前
已完结
皖公网安备34019202002308
